Cytokinetics | CYTK - Debt


Cytokinetics reported $1.2B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 54.81M 1.48M Sep/2025
Amgen USD 54.59B 1.62B Sep/2025
Arca Biopharma USD 0 0 Mar/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.29B 1.7M Dec/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 1.2B 338.79M Sep/2025
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Exelixis USD 176.46M 3.38M Sep/2025
Geron USD 121.92M 73K Sep/2025
Halozyme Therapeutics USD 1.51B 1.66M Sep/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
Ligand Pharmaceuticals USD 5.74M 5.72M Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025